Amicus Therapeutics Announces First Quarter 2019 Financial Results and Corporate Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amicus Therapeutics (FOLD) Misses Q1 EPS by 25c
May 8, 2019 7:23 AM EDTAmicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.56), $0.25 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $34 million versus the consensus estimate of $37.86 million.
GUIDANCE:
2019 Financial Guidance
For the full-year 2019 the Company anticipates total Galafold... More
